Log in

Relevant bibliographies by topics / The pharmaceutical enterprise / Books

To see the other types of publications on this topic, follow the link: The pharmaceutical enterprise.

Books on the topic 'The pharmaceutical enterprise'

Author: Grafiati

Published: 30 May 2022

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'The pharmaceutical enterprise.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Markets, Swiss Re New, and Schweizerische Rückversicherungs-Gesellschaft, eds. Risk handling and financing in pharmaceutical enterprises. Swiss Reinsurance Company, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

South Carolina. Department of Commerce. Opportunities for pharmaceutical companies in South Carolina. South Carolina Department of Commerce, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Pazderka, Bohumir. Multinational R & D activity in the pharmaceutical industry. Commission of Inquiry on the Pharmaceutical Industry; Supply and Services Canada, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Pradhan, Jaya Prakash. Overseas acquisition versus greenfield foreign investment: Which Internationalization strategy is better for Indian pharmaceutical enterprises. Institute for Studies in Industrial Development, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Dalal Consultants and Engineers Limited (Ahmedabad, India). Management Consultancy Division. and MVIRDC World Trade Centre, Bombay., eds. Impact of liberalisation and globalisation on the small & medium enterprises in the bulk drug & dyes sectors. MVIRDC World Trade Centre, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Canada. Commission of Inquiry on the Pharmaceutical Industry. Multinational r&d activity in the pharmaceutical industry. Commission of Inquiry on the Pharmaceutical Industry, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Benseba, Djamel. Les firmes multinationales pharmaceutiques et les pays en voie de développement. Office des publications universitaires, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Tewes, Stefan. Internationalisierung der japanischen Pharmaindustrie: Strategien und Perspektiven Japans auf dem Weg zum Pharmaweltmarkt. S + W Steur- und Wirtschaftsverlag, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Singh, Satwinder. Multinational corporations and Indian drug industry. Criterion Publications, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Centro Interdisciplinario de Estudios sobre el Desarrollo Uruguay. Departamento de Asesoramiento Técnico, Económico y Social., ed. La Industria farmaceútica y las transnacionales. Departamento de Asesoramiento Técnico, Económico y Social, Centro Interdisciplinario de Estudios sobre el Desarrollo-Uruguay, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Canada. Commission of Inquiry on the Pharmaceutical Industry. Multinational R and D Activity in the Pharmaceutical Industry. s.n, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Spilker, Bert. Multinational pharmaceutical companies: Principles and practices. 2nd ed. Raven Press, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

Lukanin, Aleksandr. Environmental Engineering: Processes and gas emissions purification devices. INFRA-M Academic Publishing LLC., 2017. http://dx.doi.org/10.12737/24376.

Full text

Abstract:

The tutorial adequately considered the currently existing methods of protection of the air basin from industrial waste gases of chemical, petrochemical, microbiological, pharmaceutical and related industries. The material is based on a thorough analysis of the treatment methods commonly used, the most dangerous substances that enter the Earth&#180;s atmosphere with the exhaust gases of large enterprises, also provides guidance on the use of gas-cleaning equipment emissions in the industry. Compliant with the Federal state educational standard of the latest generation of h

APA, Harvard, Vancouver, ISO, and other styles

14

Andō, Kenʾichi. Japanese multinationals in Europe: A comparison of automobile and pharmaceutical industries. Edward Elgar Pub., 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

Belisle, Jean-François. La industria farmacéutica ecuatoriana: Las multinacionales--el negocio de la salud. CEDIME, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

Sharma, Mohan Lal. Transnational firms in drug industry in South Asia. Aalekh Publishers, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Spilker, Bert. Multinational drug companies: Issues in drug discovery and development. Raven Press, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Lukanin, Alleksandr. Cleaning of gas and air emissions. INFRA-M Academic Publishing LLC., 2020. http://dx.doi.org/10.12737/1070340.

Full text

Abstract:

The monograph examines the currently existing industrial gas emissions in the chemical, petrochemical, microbiological, pharmaceutical and related industries, methods for calculating their quantity and methods for protecting the air basin from them. The materials are based on an in-depth analysis of methods for cleaning frequently occurring, most dangerous substances that enter the Earth's atmosphere with waste gases of large-scale production. Recommendations are given on methods for calculating gross emissions of harmful substances for a large number of specific industries. The subject

APA, Harvard, Vancouver, ISO, and other styles

19

Seemann, Nikolaus von. Planung des persönlichen Vertriebs im Pharmamarketing. P. Lang, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

Boom, Anette. Nationale Regulierung bei internationalen Pharma-Unternehmen: Eine theoretische Analyse der Marktwirkungen. Nomos, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

Stros, Michael. Fokus Wachstumsunternehmen: Analyse, Bewertung, Portfoliomanagement von Beteiligungen in Pharma, Biotech und Medtech. Versus, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

interviewer, Mosnier Joseph, Southern Oral History Program, University of North Carolina at Chapel Hill. Documenting the American South (Project), and University of North Carolina at Chapel Hill. Library, eds. Oral history interview with Dennis Gillings, June 10, 1999: Interview I-0072, Southern Oral History Program Collection (#4007). University Library, UNC-Chapel Hill, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

United States. Congress. House. A bill to amend the Internal Revenue Code of 1986 to deny tax benefits for research conducted by pharmaceutical companies where United States consumers pay higher prices for the products of that research than consumers in certain other countries. U.S. G.P.O., 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

Bunn, T. Davis. Elixir. WestBow Press, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

25

Maine, Sandy. Creating an herbal bodycare business. Storey Books, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

Botthof, Alfons. Zukunft der Arbeit in Industrie 4.0. Springer Nature, 2015.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

27

Miria, Grisot, Hanseth Ole, and Vassilakopoulou Polyxeni, eds. Information Infrastructures within European Health Care: Working with the Installed Base. Springer, 2016.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

28

Healy, Elaine M. The pharmaceutical industry and the Alzheimer's Disease enterprise. 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

Multinational enterprise in pharmaceutical industry and less developed countries. Centre for Development Studies, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

The Strategic Impact of Enterprise Resource Planning in the Pharmaceutical Industry. Urch Publishing Ltd, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

31

Gene Jockeys: Life Science and the Rise of Biotech Enterprise. Johns Hopkins University Press, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

32

Rasmussen, Nicolas. Gene Jockeys: Life Science and the Rise of Biotech Enterprise. Johns Hopkins University Press, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

Ltd, ICON Group. CHINA PHARMACEUTICAL ENTERPRISE: International Competitive Benchmarks and Financial Gap Analysis (Financial Performance Series). 2nd ed. Icon Group International, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

34

Ltd, ICON Group. CHINA PHARMACEUTICAL ENTERPRISE & INVEST: International Competitive Benchmarks and Financial Gap Analysis (Financial Performance Series). 2nd ed. Icon Group International, Inc., 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

35

Process Systems Engineering for Pharmaceutical Manufacturing: From Product Design to Enterprise-Wide Decision-Making. Elsevier Science & Technology Books, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

36

Peterson, Kristin. Speculative Markets: Drug Circuits and Derivative Life in Nigeria. Duke University Press, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

37

Kinch, Michael, and Lori Weiman. Price of Health: The Modern Pharmaceutical Enterprise and the Betrayal of a History of Care. Pegasus Books, 2021.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

38

Kinch, Michael, and Lori Weiman. Price of Health: The Modern Pharmaceutical Enterprise and the Betrayal of a History of Care. Pegasus Books, 2021.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

39

Peterson, Kristin. Speculative Markets: Drug Circuits and Derivative Life in Nigeria. Duke University Press, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

40

Peterson, Kristin. Speculative Markets: Drug Circuits and Derivative Life in Nigeria. Duke University Press, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

41

Speculative Markets: Drug Circuits and Derivative Life in Nigeria. Duke University Press Books, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

42

Fisher, Jill A. Adverse Events. NYU Press, 2020. http://dx.doi.org/10.18574/nyu/9781479877997.001.0001.

Full text

Abstract:

Phase I clinical trials test the safety and tolerability of new pharmaceuticals and typically pay healthy people to enroll as research participants. In addition to being exposed to the risks of taking investigational drugs, healthy volunteers are confined to residential research facilities for some portion of the clinical trial. Most healthy volunteers are African American and Hispanic men in their late twenties to early forties. Motivated by pervasive economic insecurity and racial discrimination, these individuals often enroll serially in Phase I trials to stay afloat or to get ahead. This b

APA, Harvard, Vancouver, ISO, and other styles

43

Medicine, Institute of, Board on Health Sciences Policy, Rebecca A. English, Forum on Drug Discovery, Development, and Translation, and Anne B. Claiborne. Envisioning a Transformed Clinical Trials Enterprise in the United States : Establishing an Agenda for 2020: Workshop Summary. National Academies Press, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

44

Medicine, Institute of, Board on Health Sciences Policy, Rebecca A. English, Forum on Drug Discovery, Development, and Translation, and Anne B. Claiborne. Envisioning a Transformed Clinical Trials Enterprise in the United States : Establishing an Agenda for 2020: Workshop Summary. National Academies Press, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

45

Weisfeld, Neil, Board on Health Sciences Policy, Rebecca A. English, Forum on Drug Discovery, Development, and Translation, and Anne B. Claiborne. Envisioning a Transformed Clinical Trials Enterprise in the United States : Establishing an Agenda for 2020: Workshop Summary. National Academies Press, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

46

Hauptman, Oscar, and Sloan School of Management. Formation and Early Growth of Biomedical and Pharmaceutical Enterprises. Creative Media Partners, LLC, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

47

Barker, Richard. Introduction: The growing innovation gap in life sciences. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198737780.003.0001.

Full text

Abstract:

We live in a world caught up in ever more rapid technological advance. Every week brings new IT products and services. Sectors as diverse as transport, energy, communications, and food are all bringing forward new ways to satisfy human need. However, biomedical innovation remains stubbornly slow and unproductive, as measured by output (benefit to patients) over input (investment). In fact, pharmaceutical innovation follows ‘Eroom’s Law’– an exponential decline in productivity that is the very reverse of Moore’s Law. This is despite very rapid progress in the underlying science. This ‘innovatio

APA, Harvard, Vancouver, ISO, and other styles

48

Relationship among Governance Structure, R & d Investment and Performance of Pharmaceutical Enterprises. GRIN Verlag GmbH, 2019.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

49

Pryor, Anne Elizabeth. Multinational corporations and states: The 1984 Mexican pharmaceutical decree. 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

50

Perri, Alessandra, and Enzo Peruffo. Family Business and Technological Innovation: Empirical Insights from the Italian Pharmaceutical Industry. Springer International Publishing AG, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!